Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID-19 severe or critically meta-analysis

Singh (TD-0903 10mg)
  NCT04402866		 RCTTD-0903 1mgCOVID-19 severe or criticallysome concern
6/6 ongoing
    Singh (TD-0903 1mg)
          NCT04402866    		 RCTTD-0903placeboCOVID-19 severe or criticallysome concern
    		6/6 inconclusive
      Singh (TD-0903 3mg)
              NCT04402866      		 RCTTD-0903 3mgplaceboCOVID-19 severe or criticallysome concern
      		7/6 inconclusive

        PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
        Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).

         

        - About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons